Journal article
Obesity is associated with previous suicide attempts in bipolar disorder
FA Gomes, M Kauer-Sant'Anna, PV Magalhães, FN Jacka, S Dodd, CS Gama, A Cunha, M Berk, F Kapczinski
Acta Neuropsychiatrica | CAMBRIDGE UNIV PRESS | Published : 2010
Abstract
Objective: There is a paucity of data about risk factors for suicide attempts in bipolar disorder. The aim of this study is to examine the association between suicide attempts and obesity in people with bipolar disorder. Methods: Two hundred fifty-five DSM-IV out-patients with bipolar disorder were consecutively recruited from the Bipolar Disorder Program at Hospital das Clínicas de Porto Alegre and the University Hospital at the Universidade Federal de Santa Maria, Brazil. Diagnosis and clinical variables were assessed with Structured Clinical Interview for DSM-IV-axis I (SCID I) and Program structured protocol. History of suicide attempts was obtained from multiple information sources incl..
View full abstractGrants
Funding Acknowledgements
This research was partially supported by a grant from FIPE-HCPADr P. V. M. is supported by a doctoral scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil.Dr K.-S. A. is supported by a CNPq post-doctoral scholarship and is a NARSAD Young Investigator; she has been an investigator in clinical trials sponsored by the Canadian Institutes of Health Research, and Stanley Foundation and has received salary support from an APA/Astra-Zeneca unrestricted educational grant.Ms F. N. J has received support from the Australian Rotary Health fund, University of Melbourne, and the National Health and Medical Research Council.Dr S. D. has received grant/research support from the Stanley Medical Research Foundation, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Organon, Novartis, Mayne Pharma, Servier and Astra-Zeneca. He has been a paid speaker for Eli Lilly.Dr C. S. G. has received grant/research support from CNPq, FIPE-HCPA, Endeavour Award-Australia. She has been a paid speaker for Lundbeck and Astra-Zeneca.Dr A. C. declares no financial ties.Dr M. B. has received grant/research support from Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Novartis, Mayne Pharma, Servier. He has been a paid speaker for Astra-Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen-Cilag, Lundbeck, Pfizer, Sanofi Synthelabo, Servier, Solvay, Wyeth; has been a consultant for Astra-Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen-Cilag, Lundbeck, Servier.Dr F. K. has received grant/research support from Astra-Zeneca, Eli Lilly, the Janssen-Cilag, Servier, CNPq, CAPES, NARSAD and the Stanley Medical Research Institute; has been a member of the speaker's boards for Astra-Zeneca, Eli Lilly, Janssen and Servier; and has served as a consultant for Servier.